DYRK1B and neoplasm: Also, Ccdc97 and Znf581 were positively correlated with Dyrk1B expression and might be involved in Dyrk1B-mediated tumor malignancy in patients with TNBC, suggesting Dyrk1B as a potential therapeutic target for TNBC.